Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.28B | 36.72B | 45.71B | 45.58B | 43.81B | 44.97B | Gross Profit |
6.15B | 12.26B | 14.86B | 15.01B | 13.72B | 14.29B | EBIT |
2.38B | 3.67B | 4.46B | 5.37B | 3.42B | 3.62B | EBITDA |
6.09B | 14.78B | 11.77B | 13.00B | 13.60B | 14.08B | Net Income Common Stockholders |
1.06B | 1.14B | 11.84B | 2.24B | 59.00M | -920.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
26.65B | 10.53B | 18.48B | 14.73B | 11.87B | 19.53B | Total Assets |
142.86B | 144.35B | 155.52B | 154.05B | 155.06B | 168.17B | Total Debt |
52.95B | 54.36B | 61.50B | 67.18B | 66.80B | 69.63B | Net Debt |
39.32B | 48.18B | 49.80B | 59.68B | 60.98B | 56.08B | Total Liabilities |
79.42B | 83.35B | 91.04B | 96.98B | 97.25B | 105.54B | Stockholders Equity |
62.22B | 59.97B | 63.40B | 54.78B | 55.80B | 61.41B |
Cash Flow | Free Cash Flow | ||||
3.46B | 9.70B | 13.10B | 13.53B | 11.80B | 12.20B | Operating Cash Flow |
5.64B | 16.56B | 18.05B | 18.08B | 17.21B | 17.38B | Investing Cash Flow |
2.47B | -6.12B | -379.00M | -6.87B | -9.26B | -8.09B | Financing Cash Flow |
-7.33B | -15.86B | -13.43B | -9.71B | -15.20B | -9.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $136.53B | 9.07 | 19.24% | 3.30% | 1.78% | 11.62% | |
76 Outperform | $195.82B | 18.18 | 10.54% | 4.09% | -0.08% | -24.48% | |
76 Outperform | $304.42B | 27.44 | 17.93% | 1.15% | 3.62% | 38.24% | |
74 Outperform | $59.18B | 10.61 | 38.11% | ― | 0.88% | 16.44% | |
73 Outperform | $195.71B | 11.11 | 18.27% | 5.83% | 0.61% | 50.39% | |
71 Outperform | $23.42B | 9.18 | 4.31% | 7.39% | -24.84% | -74.77% | |
59 Neutral | $30.54B | 0.25 | -13.23% | 4.04% | 2.36% | -49.53% |